FindTrial
Sign In

Study of hepatitis B immunoglobulin in assisted reproductive technology

Study of hepatitis B immunoglobulin in assisted reproductive technology

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-BOC-16009646
Enrollment
Unknown
Registered
2016-10-27
Start date
2016-11-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatitis B

Interventions

experiment group:using human hepatitis B immunoglobulin
contrast group:No

Sponsors

Assisted Reproduction Center, Northwest women and children's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. IVF patients with HBV-DNA positive; 2. HBV-DNA=10E7.

Exclusion criteria

Exclusion criteria: No

Design outcomes

Primary

MeasureTime frame
HBV-DNA copies;—

Countries

China

Contacts

Public ContactShi Wenhao

Northwest Women and Children's Hospital

swihao@126.com+86 15771798519

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026